BREAKING NEWS: Summary Judgment, Claim Construction, Consolidation, Bifurcation, and Trial Schedule Order Issued in Janssen v. Celltrion

Following three days of hearings in Janssen v. Celltrion, the District Court for the District of Massachusetts (J. Wolf) today issued a memorandum order summarizing the Court’s rulings on several pending motions in the case.

  • The Court granted Defendants’ Motion for Summary Judgment of Invalidity of the ’471 patent on both grounds raised by the Defendants (the so-called “Gilead” and “reexam” motions).
  • The Court allowed a motion to supplement the claim construction record and construed the disputed term “cell culture media” in the ’083 patent to mean “nutritive media for culturing cells.”
  • Plaintiffs’ motion for an expedited trial on the ’083 patent was withdrawn.
  • The Court granted Plaintiffs’ motion to consolidate a second filed case in the District Court (No. 16-cv-11117) with this case, and to bifurcate the damages issues.
  • The Court scheduled trial to begin on February 13, 2017.

Stay tuned to the Big Molecule Watch for further developments.

Download PDF